The University of California, Los Angeles (UCLA) was awarded a $755,650 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Validation of Biomarkers of Post-Traumatic Seizures in an Optimized Model of Traumatic Brain Injury". The award period runs from July 1, 2024 to June 30, 2026. As the prime grantee, UCLA will leverage its research capabilities, facilities, and faculty...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the U.S. Department of Health and Human Services, under the Federal Grant Program "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286), aims to develop and assess novel frameworks for accurately predicting functional recovery following moderate-to-severe traumatic brain injury (TBI). The $389,813 award to the University of...
This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
The University of California, Los Angeles (UCLA) was awarded a $721,235 Project Grant from the Department of Defense (DOD) Military Medical Research and Development program (CFDA 12.420) to conduct computational electroencephalography (EEG) analysis to predict the emergence, treatment response, and relapse of infantile spasms in children with tuberous sclerosis complex. The project will run from May 2024 to May 2027. As the prime grantee, UCLA will leverage its research capabilities, facilities,...
This federal Project Grant award of $2,790,262 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides funding to The University of Texas Health Science Center at San Antonio to conduct research on the treatment of traumatic brain injury (TBI)-related tinnitus and comorbid post-traumatic stress disorder (PTSD). The research aims to examine neurobiological markers related to symptom improvement, with a focus on identifying cognitive,...
This federal Project Grant award of $2,699,157.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research on the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The grant was awarded to the University of Pittsburgh on July 1, 2025, with a final completion date of June 30, 2029. The research...